Latest News

Filters close
Released: 7-Apr-2021 9:00 AM EDT
Rethink Announces First-Ever Protocol to Ensure Children with Autism Get the Right Level of Treatment
Rethink First

Behavioral health providers now have access to an evidence-based standard to guide customized treatment plans

Released: 16-Jun-2011 9:00 AM EDT
Oncologist Reviews the FDA-Avastin Decision
Fredericksburg Oncology

Controversy over the F.D.A.’s proposal to withdraw approval of Avastin (bevacizumab) for breast cancer treatment will reignite June 28-29 with a new round of hearings. One oncologist who will be monitoring the hearings is Dr. Frederick C. Tucker Jr. of Fredericksburg Oncology in Virginia, whose recent New York Times op ed defended the F.D.A.’s position on scientific grounds.

  • Previous Page
  • Next Page

Showing results

13 of 3